Jonathan R Branch

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Prostate Cancer

High Throughput

Top Venues

Cancer research communications

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Lucie Van Emmenis, Sheng Yu Ku, Kaitlyn M Gayvert, Jonathan R Branch, Nicholas J Brady, Subhasree Basu, Michael Russell, Joanna Cyrta, Aram Vosoughi, Verena Sailer, Hussein Alnajar, Etienne Dardenne, Elena Koumis, Loredana Puca, Brian D Robinson, Michael D Feldkamp, Annmarie Winkis, Nathan Majewski, Brent Rupnow, Marco M Gottardis, Olivier Elemento, Mark A Rubin, Himisha Beltran, David S Rickman
The Identification of CELSR3 and Other Potential Cell Surface Targets in Neuroendocrine Prostate Cancer. Cancer research communications 3 (8) (2023)
Zhuming Zhang, Peter J Connolly, Luis Trabalón Escolar, Christian Rocaboy, Vineet Pande, Lieven Meerpoel, Heng-Keang Lim, Jonathan R Branch, Janine Ondrus, Ian Hickson, Tammy L Bush, James R Bischoff, Gilles Bignan
Spirocyclic Thiohydantoin Antagonists of F877L and Wild-Type Androgen Receptor for Castration-Resistant Prostate Cancer. ACS medicinal chemistry letters 12 (8) (2021)
Zhuming Zhang, Peter J Connolly, Heng Keang Lim, Vineet Pande, Lieven Meerpoel, Christopher Teleha, Jonathan R Branch, Janine Ondrus, Ian Hickson, Tammy Bush, Leopoldo Luistro, Kathryn Packman, James R Bischoff, Salam Ibrahim, Christopher Parrett, Yolanda Chong, Marco M Gottardis, Gilles Bignan
Discovery of JNJ-63576253: A Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC). Journal of medicinal chemistry 64 (2) (2021)